These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 9638392)

  • 1. Alpha 1-antitrypsin. Hope on the horizon for emphysema sufferers?
    Schwaiblmair M; Vogelmeier C
    Drugs Aging; 1998 Jun; 12(6):429-40. PubMed ID: 9638392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation therapy of alpha 1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency.
    Blank CA; Brantly M
    Ann Allergy; 1994 Feb; 72(2):105-20; quiz 120-2. PubMed ID: 8109800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
    Hubbard RC; Sellers S; Czerski D; Stephens L; Crystal RG
    JAMA; 1988 Sep; 260(9):1259-64. PubMed ID: 3261353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
    Traclet J; Delaval P; Terrioux P; Mornex JF
    Rev Mal Respir; 2015 Apr; 32(4):435-46. PubMed ID: 25908241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-1 antitrypsin: now available, but do we need it?
    Russi EW
    Swiss Med Wkly; 2008 Apr; 138(13-14):191-6. PubMed ID: 18389391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
    Abboud RT; Ford GT; Chapman KR
    Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α1-Antitrypsin Deficiency.
    Hatipoğlu U; Stoller JK
    Clin Chest Med; 2016 Sep; 37(3):487-504. PubMed ID: 27514595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of alpha 1-antitrypsin deficiency.
    MacDonald JL; Johnson CE
    Am J Health Syst Pharm; 1995 Mar; 52(5):481-9;quiz 544-5. PubMed ID: 7606551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
    Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
    Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B; Ferrarotti I; Miravitlles M
    Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
    Wewers MD; Casolaro MA; Crystal RG
    Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant DNA-directed E.coli produced alpha 1-antitrypsin as an anti-neutrophil elastase for potential use as replacement therapy of alpha 1-antitrypsin deficiency.
    Straus SD; Fells GA; Wewers MD; Courtney M; Tessier LH; Tolstoshev P; Lecocq JP; Crystal RG
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1177-84. PubMed ID: 3896239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
    J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Practical applications of recombinant alpha-1-antitrypsin in medicine].
    Kabziński J; Kedziora J; Majsterek I
    Pol Merkur Lekarski; 2010 Dec; 29(174):345-50. PubMed ID: 21298982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Augmentation therapy with alpha-1 antitrypsin: 20 year- follow-up of a deficient patient].
    Pujazon MC; Carles P
    Rev Mal Respir; 2008 Nov; 25(9):1136-41. PubMed ID: 19106912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT.
    Dirksen A; Friis M; Olesen KP; Skovgaard LT; Sørensen K
    Acta Radiol; 1997 Sep; 38(5):826-32. PubMed ID: 9332238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.